Loading stock data...

Indrayani Biotech Limited

BSE: INDRANIB

BSE
8.12 -0.04 (-0.49%)

Prev Close

8.16

Open Price

8.18

Volume

81,392

Today Low / High

7.76 / 8.54

52 WK Low / High

7.76 / 23.49

Range

8 - 9

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 8.12, reflecting a change of -0.04 (-0.4902%). The expected target range on the BSE is 8 - 9. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

25 Feb 8.18 -0.98%
24 Feb 8.10 0.74%
23 Feb 8.60 -1.74%
20 Feb 8.50 0.12%
19 Feb 8.56 -0.35%
18 Feb 8.88 -3.83%
17 Feb 8.21 2.68%
16 Feb 8.95 -6.37%
13 Feb 8.58 -1.75%
12 Feb 8.75 -2.86%
11 Feb 8.89 -1.12%
10 Feb 8.80 0.45%
09 Feb 9.26 -6.26%
06 Feb 8.54 -3.75%
05 Feb 9.38 -8.53%
04 Feb 9.45 -0.95%
03 Feb 9.45 -2.54%
02 Feb 9.50 -3.79%
01 Feb 9.55 -2.51%
30 Jan 9.87 -2.94%
29 Jan 9.50 1.89%
28 Jan 9.30 1.83%

Indrayani Biotech Limited Graph

Indrayani Biotech Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Indrayani Biotech Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 8.12, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 8.12 8.20 7.38 - 9.02
8.28 6.63 - 9.94
8.36 5.85 - 10.87
Bearish Scenario 8.12 8.04 7.23 - 8.84
7.96 6.37 - 9.55
7.88 5.51 - 10.24

Overview of Indrayani Biotech Limited

ISIN

INE007C01021

Industry

Restaurants

Vol.Avg

52,147

Market Cap

368,843,674

Last Dividend

0

Official Website

Visit Website

IPO Date

2008-01-01

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for INDRANIB

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 130.23 Cr 82.77 Cr 47.46 Cr 0.3644 0.00 Cr 21.41 Cr 2.89 Cr -6.11 Cr -1.28 9.39 Cr -0.0469
2024-03-31 166.23 Cr 130.71 Cr 35.52 Cr 0.2137 0.00 Cr 1.02 Cr 19.86 Cr 6.36 Cr 1.75 24.66 Cr 0.0383
2023-03-31 162.93 Cr 102.21 Cr 60.71 Cr 0.3726 0.00 Cr 2.89 Cr 13.96 Cr 8.74 Cr 2.55 21.30 Cr 0.0536
2022-03-31 61.57 Cr 41.04 Cr 20.53 Cr 0.3334 0.00 Cr 0.24 Cr 6.12 Cr 4.44 Cr 1.30 7.00 Cr 0.0721
2021-03-31 21.09 Cr 15.77 Cr 5.32 Cr 0.2521 0.00 Cr 0.40 Cr -1.57 Cr -11.21 Cr -3.28 -8.79 Cr -0.5318

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.29 Cr 268.17 Cr 168.25 Cr 72.5095 Cr 137.07 Cr 136.78 Cr 41.34 Cr 60.00 Cr 0.00 Cr 0.00 Cr 0.25 Cr 102.4837 Cr
2024-03-31 0.58 Cr 235.03 Cr 158.76 Cr 67.2119 Cr 112.52 Cr 111.94 Cr 42.35 Cr 59.38 Cr 0.00 Cr 4.07 Cr -24.77 Cr 87.0723 Cr
2023-03-31 3.04 Cr 155.96 Cr 107.61 Cr 55.0871 Cr 70.19 Cr 67.15 Cr 12.21 Cr 47.85 Cr 0.77 Cr -0.01 Cr 0.22 Cr 71.9097 Cr
2022-03-31 1.50 Cr 51.40 Cr 26.83 Cr 24.1634 Cr 18.79 Cr 17.29 Cr 1.53 Cr 25.94 Cr 1.48 Cr 0.01 Cr 0.00 Cr 19.4824 Cr
2021-03-31 0.68 Cr 40.05 Cr 19.97 Cr 19.7201 Cr 15.54 Cr 14.86 Cr 1.09 Cr 25.36 Cr 0.00 Cr 0.00 Cr 0.01 Cr 11.8068 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -6.7418 Cr 24.7433 Cr -18.2954 Cr -8.1174 Cr -0.2939 Cr 0.2882 Cr -1.3756 Cr -6.1075 Cr -2.3626 Cr 0.0000 Cr 1.0086 Cr
2024-03-31 -30.3541 Cr -16.3390 Cr 44.2385 Cr -46.8414 Cr -2.4546 Cr 0.5821 Cr -16.4873 Cr 10.4225 Cr 37.2261 Cr 0.0000 Cr -30.1366 Cr
2023-03-31 16.1876 Cr -47.3935 Cr 32.7393 Cr -27.2269 Cr 1.5334 Cr 3.0367 Cr -43.4145 Cr 11.9309 Cr 22.5852 Cr 0.0000 Cr -10.6816 Cr
2022-03-31 4.1110 Cr -0.5581 Cr -2.7296 Cr 2.9035 Cr 0.8233 Cr 1.5033 Cr -1.2075 Cr 4.4395 Cr -0.8188 Cr 0.0000 Cr -0.4431 Cr
2021-03-31 0.2559 Cr -0.7022 Cr -0.2772 Cr -0.4397 Cr -0.7234 Cr 0.6787 Cr -0.6956 Cr -11.2144 Cr 1.2095 Cr 0.0000 Cr 3.9820 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 35.95 Cr 27.21 Cr 8.73 Cr 0.2430 1.15 Cr 0.91 Cr 0.20 4.25 Cr 0.0254
2025-06-30 29.10 Cr 20.76 Cr 8.35 Cr 0.2868 1.32 Cr 0.16 Cr 0.03 3.24 Cr 0.0054
2025-03-31 50.57 Cr 40.18 Cr 10.39 Cr 0.2054 -4.02 Cr -7.40 Cr -1.55 -2.96 Cr -0.1463
2024-12-31 17.32 Cr 10.13 Cr 7.18 Cr 0.4148 1.46 Cr 0.24 Cr 0.05 2.92 Cr 0.0138
2024-09-30 30.81 Cr 14.87 Cr 15.94 Cr 0.5174 2.31 Cr 1.22 Cr 0.27 5.41 Cr 0.0395

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 4.56 Cr 2.42 Cr 6.98 Cr 87.84 Cr 43.21 Cr 183.92 Cr 61.95 Cr 274.46 Cr 170.64 Cr
2025-06-30 0.00 Cr 0.00 Cr 26.50 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -99.92 Cr
2025-03-31 0.29 Cr 26.21 Cr 26.50 Cr 67.25 Cr 41.34 Cr 177.94 Cr 60.00 Cr 268.17 Cr 168.25 Cr
2024-09-30 3.13 Cr 44.44 Cr 47.57 Cr 46.65 Cr 40.76 Cr 159.96 Cr 60.91 Cr 251.68 Cr 144.05 Cr
2024-06-30 30.25 Cr 0.00 Cr 30.25 Cr 0.00 Cr 0.00 Cr 30.25 Cr 0.00 Cr 0.00 Cr -76.27 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.16 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -3.98 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.85 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 0.12 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.58 Cr 2.65 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2015-09-24 September 24, 15 3:25

Similar Stocks: Restaurants

Company Name Symbol Price Market Cap Volume
Jubilant FoodWorks Limited JUBLFOOD ₹516.65 ₹339,790,346,168.00 ₹1,113,080.00
Devyani International Limited DEVYANI ₹131.58 ₹162,221,034,600.00 ₹960,049.00
Westlife Foodworld Limited WESTLIFE ₹495.20 ₹76,950,484,353.00 ₹33,836.00
Sapphire Foods India Limited SAPPHIRE ₹213.50 ₹68,615,250,218.00 ₹122,488.00
Restaurant Brands Asia Limited RBA ₹63.66 ₹37,097,674,020.00 ₹3,075,823.00

Key Executives

Head of Human Resource
Mary Sujatha

Gender: Not Specified

Year Born:

Chief Financial Officer & Chief Co-ordinating Officer
Dhinakaran Rajagopal

Gender: male

Year Born:

Whole Time Director
Govindarajan Swaminathan

Gender: male

Year Born: 1969

Whole Time Director
Muthukrishnan Ramesh

Gender: male

Year Born: 1972

Whole Time Director
Singarababu Indirakumar

Gender: male

Year Born: 1966

Company Secretary & Compliance Officer
Ramya Ravi

Gender: female

Year Born:

MD & Executive Director
Kasiraman Sayee Sundar

Gender: male

Year Born: 1961

FAQs about Indrayani Biotech Limited

Who is the CEO of the company?

The CEO is Kasiraman Sayee Sundar.

What is the current market price of the stock?

The current price is ₹8.10.

What is the 52-week price range?

The range is ₹7.76-23.49.

What is the market capitalization of the company?

The market capitalization is ₹36.88 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -6.06.

Which sector does the company belong to?

The company operates in the Consumer Cyclical sector.

What does the company do?

Overview of Indrayani Biotech Limited (ISIN: INE007C01021) is a leading Restaurants in India. With a market capitalization of ₹36.88 crores and an average daily volume of 52,147 shares, it operates in the Restaurants. The company last declared a dividend of ₹0.